Myriad Genetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.08.16	Myriad Genetics Inc. Q4 Profit Drops 10% (RTTNews)
11.07.16	Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute (GlobeNewswire)
29.06.16	Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer (RTTNews)
31.05.16	Myriad Acquires Sividon Diagnostics (GlobeNewswire)
03.05.16	Myriad Genetics Inc. Earnings Advance 2% In Q3 (RTTNews)
03.05.16	Myriad Genetics Updates FY16 Guidance; Q3 Profit Tops Estimates (RTTNews)
30.03.16	Myriad: MyRisk Test Identifies 70% More Deleterious Mutations Than BRCA Testing (RTTNews)
22.02.16	Myriad Expands Diagnostic Research Collaboration With Tesaro, Merck (RTTNews)
02.02.16	Myriad Genetics Raises FY16 Earnings Guidance - Quick Facts (RTTNews)
02.02.16	Myriad Genetics Inc. Reveals 12% Increase In Q2 Profit (RTTNews)
03.11.15	Myriad Genetics Inc. Q1 Profit Rises 54% (RTTNews)
08.10.15	Myriad To Highlight New Data On MyPath Melanoma At ASDP Meeting - Quick Facts (RTTNews)
01.10.15	Myriad Appoints Jan Schluchter as Chief Commercial Officer for Europe (GlobeNewswire)
24.09.15	Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting (GlobeNewswire)
11.08.15	Myriad Genetics Profit Misses Estimates, Outlook Weak; Stock Down 4% (RTTNews)
11.08.15	EARNINGS SUMMARY: Details of Myriad Genetics Inc. Q4 Earnings Report (RTTNews)
29.05.15	Myriad Significantly Advances The MyChoice HRD Companion Diagnostic Test (RTTNews)
05.05.15	Myriad Genetics Posts Lower Q3 Profit; Cuts FY15 Outlook Again (RTTNews)
01.04.15	Myriad, AstraZeneca Expand Research Collaboration On Lynparza - Quick Facts (RTTNews)
20.03.15	Myriad Genetics Announces Prolaris Test Biopsy Results From EMPATHY-P Study (RTTNews)
20.03.15	Myriad Announces Prolaris(R) Test Biopsy Results From EMPATHY-P Study at European Association of Urology Annual Meeting (GlobeNewswire)
20.03.15	Myriad Announces Prolaris(R) Test Biopsy Results From EMPATHY-P Study at European Association of Urology Annual Meeting (GlobeNewswire)
17.03.15	Myriad Genetics Expands Collaboration With BioMarin Pharma (RTTNews)
09.02.15	Quest Diagnostics, Myriad Genetics End BRCA Gene-patent Litigation - Quick Facts (RTTNews)
04.02.15	Myriad Genetics Plunge 15% On Weak Outlook, But Q2 Adj Profit Tops View (RTTNews)
03.02.15	Myriad Results Top Estimates, Cuts FY Outlook; CEO Medrum To Retire In June (RTTNews)
29.01.15	Making Peace With Rivals For A Slice Of BRCA... (RTTNews)
08.01.15	Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors (GlobeNewswire)
22.12.14	Myriad Genetics Appoints Bernard Tobin As President Of Crescendo Bioscience (RTTNews)
22.12.14	JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice (RTTNews)
20.11.14	TESARO, Myriad Announce Companion Diagnostics Collaboration - Quick Facts (RTTNews)
05.11.14	Myriad Genetics Q1 Results Miss Estimates, Issues Weak Q2 Outlook (RTTNews)
05.11.14	Myriad Genetics Q1 Profit Decreases - Quick Facts (RTTNews)
24.10.14	Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe (GlobeNewswire)
08.10.14	Myriad Names Bryan Riggsbee CFO - Quick Facts (RTTNews)
13.08.14	Myriad Genetics Q4 Profit Down, Details Weak Outlook; Shares Down (RTTNews)
12.08.14	Myriad Genetics Q4 Profit Tops Estimate; Guides FY15 EPS Below Consensus (RTTNews)
09.06.14	Myriad CFO James Evans To Retire (RTTNews)
06.05.14	Myriad Genetics Q3 Profit Tops View; Lifts FY14 Outlook - Quick Facts (RTTNews)
07.04.14	Myriad Genetics Submits Premarket Approval Application For BRACAnalysis (RTTNews)
05.02.14	Safeguard Scientifics: Partner Firm Crescendo To Be Acquired By Myriad Genetics (RTTNews)
05.02.14	Myriad Genetics Profit Up, To Acquire Crescendo Bioscience; Stock Jumps 14% (RTTNews)
04.02.14	After-market Movers For Feb 4 (MYGN, DATA, USNA, CHRW) (RTTNews)
04.02.14	Myriad Genetics Q2 Profit Rises; Lifts FY14 Outlook - Quick Facts (RTTNews)
04.02.14	Myriad Genetics To Buy Crescendo Bioscience (RTTNews)
13.12.13	CRMD Awaits Makeover, INSY In Crosshairs, Plandaí On A High, SNTA Enchants (RTTNews)
21.11.13	PETX On The Move, IMGN To Pocket $5Mln, RGLS Gets Richer, MYGN Does It Again (RTTNews)
06.11.13	Pre-market Movers For Nov 6 (TWX, MSPD, MYGN, HUM, TSLA, ANF, CRIS) (RTTNews)
06.11.13	MYGN, SGEN Boost Outlook, AMRI On A High, ENDP Opens Wallet, IMGN Slammed (RTTNews)
06.11.13	Myriad Genetics Boosts 2014 Outlook As Q1 Results Top Estimates; Shares Up 9% (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18:01		Angespannte Stimmung in New York: NASDAQ Composite verbucht am Mittag Abschläge
08.01.25		NASDAQ Composite-Handel aktuell: NASDAQ Composite schwächelt am Nachmittag
07.01.25		Schwacher Handel in New York: NASDAQ Composite zum Ende des Dienstagshandels leichter
12.12.24		Schwacher Handel: NASDAQ Composite am Donnerstagmittag schwächer
11.12.24		Gute Stimmung in New York: NASDAQ Composite zum Handelsende mit Gewinnen
10.12.24		Börse New York: NASDAQ Composite liegt am Mittag im Plus
06.12.24		NASDAQ Composite aktuell: NASDAQ Composite letztendlich im Plus
06.12.24		Freitagshandel in New York: NASDAQ Composite nachmittags in Grün

18:01

Angespannte Stimmung in New York: NASDAQ Composite verbucht am Mittag Abschläge

08.01.25

NASDAQ Composite-Handel aktuell: NASDAQ Composite schwächelt am Nachmittag

07.01.25

Schwacher Handel in New York: NASDAQ Composite zum Ende des Dienstagshandels leichter

12.12.24

Schwacher Handel: NASDAQ Composite am Donnerstagmittag schwächer

11.12.24

Gute Stimmung in New York: NASDAQ Composite zum Handelsende mit Gewinnen

10.12.24

Börse New York: NASDAQ Composite liegt am Mittag im Plus

06.12.24

NASDAQ Composite aktuell: NASDAQ Composite letztendlich im Plus

06.12.24

Freitagshandel in New York: NASDAQ Composite nachmittags in Grün

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	79.18	1.64 %	K V
CieFinRichemont	140.20	1.26 %	K V
Swiss Re	132.30	0.92 %	K V
Swiss Life Hldg	707.40	0.91 %	K V
Zurich Insur Gr	529.40	0.80 %	K V
Roche Hldg G	263.40	-0.57 %	K V
Kuehne+Nagel Int	200.00	-0.65 %	K V
Novartis	90.11	-0.75 %	K V
Givaudan	3’848.00	-0.95 %	K V
Lonza Grp	537.40	-1.29 %	K V

Nachrichten zu Myriad Genetics Inc.

Aktien Top/Flop

Myriad Genetics Peer Group Nachrichten

Meistgelesene Nachrichten